Trial Profile
Nasal Fentanyl for Patient Controlled Treatment of Pain in Cancer An Open Label Prospective Phase I b Study.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 22 Dec 2011
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Adverse reactions; Therapeutic Use
- 16 Dec 2011 Actual end date (September 2011) added as reported by ClinicalTrials.gov.
- 16 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 31 Mar 2011 Status changed from not yet recruiting to recruitingas reported by ClinicalTrials.gov.